Drugs / CAR BCMA-CD70 T cells
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07416682 | Apr 2026 → Jan 2027 expected | plasma cell neoplasm | Affiliated Hospital to Academy of Military Medical Sciences | Recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CAR BCMA-CD70 T cells | “Investigational product: CAR BCMA-CD70 T cells.” NCT07416682 ↗ |
| Known as | BCMA-CD70-CAR-T cells | “Each subject will be infused with single dose of BCMA-CD70-CAR-T cells.” NCT07416682 ↗ |
| Modality | Cell therapy | “CAR BCMA-CD70 CAR-T cell therapy” NCT07416682 ↗ |
| Route | Intravenous | “Route of administration: Intravenous injection.” NCT07416682 ↗ |